These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 19156588

  • 1. Terlipressin in 30 patients with hepatorenal syndrome: results of a retrospective study.
    von Kalckreuth V, Glowa F, Geibler M, Lohse AW, Denzer UW.
    Z Gastroenterol; 2009 Jan; 47(1):21-6. PubMed ID: 19156588
    [Abstract] [Full Text] [Related]

  • 2. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
    Martín-Llahí M, Pépin MN, Guevara M, Díaz F, Torre A, Monescillo A, Soriano G, Terra C, Fábrega E, Arroyo V, Rodés J, Ginès P, TAHRS Investigators.
    Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
    [Abstract] [Full Text] [Related]

  • 3. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response.
    Sharma P, Kumar A, Shrama BC, Sarin SK.
    Am J Gastroenterol; 2008 Jul; 103(7):1689-97. PubMed ID: 18557715
    [Abstract] [Full Text] [Related]

  • 4. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.
    Ortega R, Ginès P, Uriz J, Cárdenas A, Calahorra B, De Las Heras D, Guevara M, Bataller R, Jiménez W, Arroyo V, Rodés J.
    Hepatology; 2002 Oct; 36(4 Pt 1):941-8. PubMed ID: 12297842
    [Abstract] [Full Text] [Related]

  • 5. Terlipressin therapy for renal failure in cirrhosis.
    Triantos CK, Samonakis D, Thalheimer U, Cholongitas E, Senzolo M, Marelli L, Leandro G, Patch D, Burroughs AK.
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):481-6. PubMed ID: 19952764
    [Abstract] [Full Text] [Related]

  • 6. Terlipressin and albumin combination treatment in hepatorenal syndrome.
    Danalioglu A, Cakaloglu Y, Karaca C, Aksoy N, Akyuz F, Ozdil S, Demir K, Besisik F, Boztas G, Mungan Z, Kaymakoglu S, Okten A.
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccciii-cccv. PubMed ID: 15244209
    [Abstract] [Full Text] [Related]

  • 7. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials.
    Sagi SV, Mittal S, Kasturi KS, Sood GK.
    J Gastroenterol Hepatol; 2010 May; 25(5):880-5. PubMed ID: 20074149
    [Abstract] [Full Text] [Related]

  • 8. Long-term outcome of patients treated with terlipressin for types 1 and 2 hepatorenal syndrome.
    Testro AG, Wongseelashote S, Angus PW, Gow PJ.
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1535-40. PubMed ID: 17784863
    [Abstract] [Full Text] [Related]

  • 9. Long-term treatment of hepatorenal syndrome as a bridge to liver transplantation.
    Caraceni P, Santi L, Mirici F, Montanari G, Bevilacqua V, Pinna AD, Bernardi M.
    Dig Liver Dis; 2011 Mar; 43(3):242-5. PubMed ID: 20833118
    [Abstract] [Full Text] [Related]

  • 10. Terlipressin in hepatorenal syndrome: Evidence for present indications.
    Rajekar H, Chawla Y.
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521
    [Abstract] [Full Text] [Related]

  • 11. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.
    Boyer TD, Sanyal AJ, Wong F, Frederick RT, Lake JR, O'Leary JG, Ganger D, Jamil K, Pappas SC, REVERSE Study Investigators.
    Gastroenterology; 2016 Jun; 150(7):1579-1589.e2. PubMed ID: 26896734
    [Abstract] [Full Text] [Related]

  • 12. Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome.
    Nazar A, Pereira GH, Guevara M, Martín-Llahi M, Pepin MN, Marinelli M, Solá E, Baccaro ME, Terra C, Arroyo V, Ginès P.
    Hepatology; 2010 Jan; 51(1):219-26. PubMed ID: 19877168
    [Abstract] [Full Text] [Related]

  • 13. Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study.
    Ghosh S, Choudhary NS, Sharma AK, Singh B, Kumar P, Agarwal R, Sharma N, Bhalla A, Chawla YK, Singh V.
    Liver Int; 2013 Sep; 33(8):1187-93. PubMed ID: 23601499
    [Abstract] [Full Text] [Related]

  • 14. Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study.
    Alessandria C, Ottobrelli A, Debernardi-Venon W, Todros L, Cerenzia MT, Martini S, Balzola F, Morgando A, Rizzetto M, Marzano A.
    J Hepatol; 2007 Oct; 47(4):499-505. PubMed ID: 17560680
    [Abstract] [Full Text] [Related]

  • 15. Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: a case-control study.
    Alessandria C, Debernardi-Venon W, Carello M, Ceretto S, Rizzetto M, Marzano A.
    Dig Liver Dis; 2009 Apr; 41(4):298-302. PubMed ID: 19158001
    [Abstract] [Full Text] [Related]

  • 16. Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study.
    Mulkay JP, Louis H, Donckier V, Bourgeois N, Adler M, Deviere J, Le Moine O.
    Acta Gastroenterol Belg; 2001 Apr; 64(1):15-9. PubMed ID: 11322061
    [Abstract] [Full Text] [Related]

  • 17. Terlipressin. Type I hepatorenal syndrome: an extra window of time before liver transplantation.
    Prescrire Int; 2006 Dec; 15(86):220. PubMed ID: 17171813
    [Abstract] [Full Text] [Related]

  • 18. Terlipressin and gelafundin: safe therapy of hepatorenal syndrome.
    Saner F, Kavuk I, Lang H, Biglarnia R, Frühauf NR, Schäfers RF, Malagó M, Broelsch CE.
    Eur J Med Res; 2004 Feb 27; 9(2):78-82. PubMed ID: 15090293
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
    Krag A, Borup T, Møller S, Bendtsen F.
    Adv Ther; 2008 Nov 27; 25(11):1105-40. PubMed ID: 19018483
    [Abstract] [Full Text] [Related]

  • 20. Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis.
    Colle I, Durand F, Pessione F, Rassiat E, Bernuau J, Barrière E, Lebrec D, Valla DC, Moreau R.
    J Gastroenterol Hepatol; 2002 Aug 27; 17(8):882-8. PubMed ID: 12164964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.